Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Publication Policies and Ethics

Useful Links

Share This Page

Vulvar Cancer

This cancer involves both the vulva and the vagina is considered as vulvar cancer. Vulvar cancer is a rare type of cancer. It forms in a woman's external genitals, called the vulva. The cancer usually grows slowly over several years. First, precancerous cells grow on vulvar skin. This is called vulvar intraepithelial neoplasia or dysplasia. Not all vulvar intraepithelial neoplasia cases turn into cancer, but it is best to treat it early.

Vulvar Cancer Related Journals
Journal of Cervical Cancer, Journal of Adolescent Health, ancer Treatment Reviews, ournal of Cancer Biology & Research, Journal of Gynecology, American Journal of Cancer Prevention.

Vulvar Cancer

Expert PPTs

Jun Yang
Histopathology and pathogenesis of digestive system and Female genital and breast tumors
PPT Version | PDF Version
He Wang
Cytopathology
PPT Version | PDF Version
Dr. Sarfraz Ahmad
Lonnie Zeltzer
Dr. Lonnie Zeltzer, Director, Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences
PPT Version | PDF Version
Aruna Turaka
Intensity modulated radiation therapy
PPT Version | PDF Version
Hosam A Elbaz
Characterization of the pharmacological effects of cardiac glycosides on lung epithelial cells
PPT Version | PDF Version
You Mie Lee
Cell signalling and Biochips
PPT Version | PDF Version

Speaker PPTs

Rongtuan Lin
Modulating the Antioxidant Defences to Potentiate Oncolytic Virotherapy in Refractory Cancer Cells
PPT Version | PDF Version
Ganapathi Bhat Mugulthimoole
Unmasking the masquerading cancer cells: have we made progress with the revival of immunotherapy?
PPT Version | PDF Version
Moshe Giladi
Tumor Treating Fields (TTFields) induced cancer cell death may be immunogenic resulting in enhanced antitumor efficacy when combined with immune-modulating therapy
PPT Version | PDF Version
Ping Yang
Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
| PDF Version
Daniel S Peiffer
Dietary consumption of black raspberries or their anthocyanin constituents alters innate immune cell trafficking in esophageal cancer
| PDF Version
Afsar Rahbar
Studies of the importance of Cytomegalovirus infection in breast cancer
PPT Version | PDF Version
Mervi Siekkinen
Effect of e-feedback on knowledge about radiotherapy of breast cancer patients
PPT Version | PDF Version
Inge Verbrugge
Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applications
PPT Version | PDF Version
Carolina Alonso-GonzÃ¡lez
Melatonin sensitizes human breast cancer cells to ionizing radiation
PPT Version | PDF Version
Guldeniz Karadeniz Cakmak
The importance of intraoperative ultrasound guidance to achieve negative margins for palpable and nonpalpable breast cancer
PPT Version | PDF Version
Sribatsa Kumar Mahapatra
Triple ABC Technique in Clinical Assessment in Breast Cancer Diagnosis
PPT Version | PDF Version
Daisuke Ota
The clinical outcome of reconstruction with tissue expander for breast cancer patients with mastectomy
PPT Version | PDF Version
Nicolae Bacalbasa
The benefits of surgery for breast cancer liver metastases Ã¢â¬â a single center experience
PPT Version | PDF Version
Ozlem Tokusoglu
Phenolics and Cancer
| PDF Version
Sitanshu Sekhar Lahiri
A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery
PPT Version | PDF Version
Stefan B EichmÃ¼ller
Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
| PDF Version
Thomas Kieber-Emmons
Developing a first in man carbohydrate mimetic peptide vaccine for cancer: A translational story
| PDF Version
Yi-Cheng Hu
Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifentreated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study
PPT Version | PDF Version
Daniel H. Snyder
Breast cancer in young age (Ã¢â°Â¤40 years): The University of Tennessee Medical Center at Knoxville 10 year experience
PPT Version | PDF Version
Mieke Van Hemelrijck
A role for lipids and statins in breast cancer risk and prevention?
PPT Version | PDF Version
Piwen Wang
Enhanced chemopreventive effect by combining Quercetin and green tea in prostate cancer
| PDF Version
Gaspar Banfalvi
Origin of breast cancer metastasis
PPT Version | PDF Version
San Ming Wang
Unknown genetic predisposition in familial breast cancer can lie deep in family tree
PPT Version | PDF Version
Vicente Marco
Changes in breast cancer pathology reports after second opinion
PPT Version | PDF Version
Christopher Busby
The breast cancer epidemic: Evidence for a radiogenic cause
PPT Version | PDF Version
Saroj Velamakanni
Multiparameter analysis using cell cycle biomarkers for breast cancer: Prognostic and predictive implications
PPT Version | PDF Version
Benjamin Y. M. Yung
A Big Data Analysis Platform to Unveil Gene Interactions in Cancer
PPT Version | PDF Version
Jalal Poorolajal
The effect of body mass index on endometrial cancer: A meta-analysis
PPT Version | PDF Version
Tatiana V Macfarlane
Aspirin use and risk of Head and Neck Cancer: evidence from the INHANCE consortium
PPT Version | PDF Version
Babak Behnam
SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer
PPT Version | PDF Version
Yosef Yarden
Classically, the 3Ã¢â¬â¢untranslated region (3Ã¢â¬â¢UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3Ã¢â¬â¢UTR alone, without all other elements in mRNA such as 5Ã¢â¬â¢UTR and coding region. The importance of independent 3Ã¢â¬â¢UTR RNA (referred as I3Ã¢â¬â¢UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3Ã¢â¬â¢UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3Ã¢â¬â¢UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3Ã¢â¬â¢UTR were important for its tumor suppression activity. Then, the C/EBP 3Ã¢â¬â¢UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3Ã¢â¬â¢UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3Ã¢â¬â¢UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990Ã¢â¬â¢s to 2000Ã¢â¬â¢s, world scientists found several 3Ã¢â¬â¢UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3Ã¢â¬â¢UTR regions, although the existence of their transcribed products as independent 3Ã¢â¬â¢UTR RNAs is still to be confirmed. Our studies indicate that the independent 3Ã¢â¬â¢UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
PPT Version | PDF Version
Suoqin Tang
Survivin siRNA nano particles are capable of inhibiting liver cancer cell growth both in vitro and in vivo
PPT Version | PDF Version
Eli Raveh
From chromosomal instability to metastases- H19Ã¢â¬â¢s role in cancer progression and its clinical significance
PPT Version | PDF Version
Hugo Albrecht
Towards pharmacological validation of MNKs as anti-cancer drug targets
PPT Version | PDF Version
Wei Duan
Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
PPT Version | PDF Version
Lourdes Cortes Dericks
Cancer Stem Cell Markers in Lung Cancer: Proofs of Concept and Some Reservations
PPT Version | PDF Version
Huidi Liu
Reduced Expression of SOX7 in Ovarian Cancer: a Novel Tumor Suppressor through the Wnt/ÃÂ²-catenin Signaling Pathway
PPT Version | PDF Version
Isabelle De Waziers
Use of engineered mesenchymal stem cells against cancers
PPT Version | PDF Version
Soha M Hamdy
Biochemical studies on the effect of turmeric on breast cancer of rats
PPT Version | PDF Version
Maria da GraÃ§a Justo Araujo
Fanconi anemia: Immune deficiency and susceptibility to cancer
PPT Version | PDF Version
Pi-Wan Cheng
Disregulation of Golgi localization of glycosyltransferases alters mucin O-glycosylation and survival or metastatic properties of cancer cells
PPT Version | PDF Version
Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
PPT Version | PDF Version
Medhat Faris
Patient advocacy program for breast cancer patients in the eastern province
PPT Version | PDF Version
Jose Roberto Piato
Improved frozen section examination of the retroareolar margin for prediction of nipple involvement in breast cancer
PPT Version | PDF Version
Ewa Maj
Antiangiogenic treatment in non-small cell lung cancer (NSCLC)
PPT Version | PDF Version
James A Bonner
Anti-EGFr monoclonal antibody therapy in Head and Neck cancer
PPT Version | PDF Version
Francis Mussai
Tumour arginine addiction subverts the anti-cancer immune response
PPT Version | PDF Version
Saif Uddin Ahmed
Breast Cancer: Presentation & limitation oftreatment - Bangladesh perspective
PPT Version | PDF Version
Punit Kaur
A Mouse Model for Triple-Negative Breast Cancer Stem Cells (TNBC-CSC) Exhibits an Aggressive Phenotype
PPT Version | PDF Version
Matthew Curzon, M.D.
Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience
PPT Version | PDF Version
Heather Gage
HER2+ breast cancer: Pre and post adjuvant anti-HER2 therapy era - the University of Tennessee Medical Center at Knoxville 11 year experience
PPT Version | PDF Version
Peter Weightman
A new approach to the diagnosis of cervical, oesophageal and prostate cancer based on a combination of infrared and terahertz techniques
PPT Version | PDF Version
Fabienne Meier-Abt
Mechanisms of Early Pregnancy-Mediated Breast Cancer Protection
PPT Version | PDF Version
Federico Cattin
Breast cancer: A comparison among different diagnostic and therapeutic protocols
PPT Version | PDF Version
Lei Huo
Diagnostic biomarkers in metastatic breast cancer
PPT Version | PDF Version
Shareef Alqahtani
Illitracy and Breast Cancer Screening Utilization: A Case Study of Saudi Women over 60 Years of Age
PPT Version | PDF Version
Arghya Adhikary
PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a
PPT Version | PDF Version
Amila Orucevic
Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCCÃ¢â¬â¢s TNM staging system on overall survival of Caucasian females with breast cancer: An institutionÃ¢â¬â¢s 10 year experience
PPT Version | PDF Version
Phillip K. Darcy
Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinic.
PPT Version | PDF Version
Yvonne Paterson
HER-2/neu as a target forListeria-based cancer immunotherapy for breast cancer
PPT Version | PDF Version
Caigang Liu
FSIP1: A new potential early screening marker for breast cancer
PPT Version | PDF Version
Domenico Samorani
Screening of Breast Cancer from Mammography to MR Imaging
PPT Version | PDF Version
Diptendra K Sarkar
Role of NFKB as a prognostic marker in breast cancer: a new tool in the horizon
PPT Version | PDF Version
S Karthikeyan
Resveratrol modulates expression of ABC transporters in non-small lung cancer cells: Molecular docking and gene expression studies
PPT Version | PDF Version
Sushmita Pathy
Role of Radiotherapy in Multidisciplinary Management of Rectal Cancers
PPT Version | PDF Version
Dashrath Ram N Reddy
Role of Nutraceuticals in chemoprevention and cancer treatment
PPT Version | PDF Version
Praveen Kumar Saxena
Metal Burden -Cancer
PPT Version | PDF Version
Pravin D Potdar
Molecular Profiling of Cancer Cells
PPT Version | PDF Version
Shaqul Qamar Wani
Cervical Cancer: An update on the guidelines for screening
PPT Version | PDF Version
Amany Mohammed Shebl
Impact of nursing management protocol on radiotherapy induced git side effects (nausea, vomiting, and diarrhea) in patients with cancer
PPT Version | PDF Version
Kevin Carvalho de Melo Faria
Laparoscopic Gastrectomy for Gastric Cancer Treatment: Report of an Initial Experience
PPT Version | PDF Version
Peiying Yang
Role of Na, K-ATPase in Gastrointestinal Cancer
PPT Version | PDF Version
Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
PPT Version | PDF Version
Alvaro Ronco
Nutriequalization: Attempting to improve survival in cancer patients through nutritional modifications
PPT Version | PDF Version
Antonio Cilla
Antiproliferative effect of main dietary phytosterols and/or ÃÂ²-cryptoxanthin in human colon cancer Caco-2 cells through cytosolic Ca2+ - and oxidative stress-induced apoptosis
PPT Version | PDF Version
Vineeta Deshmukh
Effectiveness of Ayurvedic treatment in alleviating side-effects of radiotherapy in oropharyngeal cancer patients and its relationship with improvement in immune status of the host
PPT Version | PDF Version
Mingsong Wu
Identification of differentially expressed genes in human lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene
PPT Version | PDF Version
Dean A
Identifying physical and psycho-social issues facing breast cancer survivors after definitive treatment for early breast cancer: a nurse-led clinic model
PPT Version | PDF Version
SinYoung Kim
Health beliefs and breast cancer screening among Korean immigrant women
PPT Version | PDF Version
Shulamith Kreitler
Where, when and how to die: Insights into issues of critical nursing in cancer
PPT Version | PDF Version
Liselotte Jakobsson
Does a salutogenic attitude increase life quality after prostate cancer treatment?
PPT Version | PDF Version
Adriana Katz
Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
PPT Version | PDF Version
Tamar Geiger
Genome-Scale Proteomic Profiling of Breast Cancer Progression
PPT Version | PDF Version
Chien-Fu Hung
Mark cancer cells for CTL attack through coating with viral antigenic peptides CTLs kill tumor with viral peptides
PPT Version | PDF Version
Rahul Purwar
Engineered T cells: Next-generation cancer immunotherapy
PPT Version | PDF Version
John A. Barrett
Localized regulated expression of IL-12 as a gene therapy approach to cancer immunotherapy
PPT Version | PDF Version
Tao Lu
Using VBIM technique to identify drug resistance genes in ovarian cancer
PPT Version | PDF Version
Lydia Benhocine
Cancers, chemotherapies and hemodialysis: A retrospective study
PPT Version | PDF Version
RanjitaPallavi
Geriatric Oncology: Caring for the older patient with cancer
PPT Version | PDF Version
Lourdes Cortes-Dericks
ALDHhigh/CD44+ putative cancer stem cell population as therapeutic target in malignant pleural mesothelioma
PPT Version | PDF Version
Mark D Gorrell
The protease fibroblast activation proteinas a biomarker and therapeutic target in cancer and chronic liver injury
PPT Version | PDF Version
Daniel Rotroff
Using DNA copy number aberrations in naturally occurring canine cancers to identify candidate drivers of carcinogenesis
PPT Version | PDF Version
Ivan Mfouo-Tynga
Effects of SulfonatedZinc Phthalocyanine and Low Intensity Laser Irradiation in Inducing Photodynamic Damagein Breast Cancer Cells
| PDF Version
Mark Kester
Nanocolloidsfor Cancer
PPT Version | PDF Version
Yajun Yi
Meta-analysis of transcriptional profiles in cancer for prognosis prediction and metastatic gene identification
PPT Version | PDF Version
Vladimir Pak
Double Targeting as an Effective Anti-Cancer Strategy
PPT Version | PDF Version
Luminita Castillos
Gene expression profiling for targeted cancer treatment
PPT Version | PDF Version
Anton Yuryev
Construction of cancer pathways for personalized medicine
PPT Version | PDF Version
Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version
Maria Paola COSTI
A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
PPT Version | PDF Version
Bing Zhang
Translating multidimensional cancer omics data into biological insights
PPT Version | PDF Version
Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
PPT Version | PDF Version
Kelvin K. Tsai
Linking tissue microarchitectures to rationalized molecular diagnostics in glandular cancers
PPT Version | PDF Version
Zuping Xia
Development of Sphingosine Kinase Inhibitors for Cancer Therapy
PPT Version | PDF Version
Charles F. L. Mbakaya
Elucidating the link between environment, nutrition, host immunity, AIDS and cancer as informed by selected studies in Kenya and beyond
PPT Version | PDF Version